Research Article: Cost Analysis of High-Flow Oxygen Therapy Compared with Conventional Oxygen Therapy in Severe COVID- in Colombia: Data from a Randomized Clinical Trial
Abstract:
Most COVID- patients have either asymptomatic or mild disease, but those progressing to acute hypoxemic respiratory failure impose a substantial burden on health care systems., In pre-pandemic conditions, acute hypoxemic respiratory failure from etiologies different from SARS-CoV- infection has been related to significant increases in both hospital and Intensive Care Unit (ICU) length of stay and overall medical expenses, with cost estimations around USD . billion in the United States in .
Introduction:
Most COVID- patients have either asymptomatic or mild disease, but those progressing to acute hypoxemic respiratory failure impose a substantial burden on health care systems. , In pre-pandemic conditions, acute hypoxemic respiratory failure from etiologies different from SARS-CoV- infection has been related to significant increases in both hospital and Intensive Care Unit (ICU) length of stay and overall medical expenses, with cost estimations around USD . billion in the United States in .
Read more